Inotropic options for postresuscitation myocardial dysfunction

Crit Care Med. 2005 Mar;33(3):668-70. doi: 10.1097/01.ccm.0000155781.11773.be.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Animals
  • Cardiomyopathies / physiopathology
  • Cardiomyopathies / prevention & control*
  • Cardiopulmonary Resuscitation*
  • Cardiotonic Agents / pharmacology
  • Cardiotonic Agents / therapeutic use*
  • Dobutamine / pharmacology
  • Dobutamine / therapeutic use*
  • Heart Arrest / therapy*
  • Humans
  • Hydrazones / pharmacology
  • Hydrazones / therapeutic use*
  • Myocardial Stunning / physiopathology
  • Myocardial Stunning / prevention & control*
  • Pyridazines / pharmacology
  • Pyridazines / therapeutic use*
  • Simendan
  • Swine

Substances

  • Cardiotonic Agents
  • Hydrazones
  • Pyridazines
  • Simendan
  • Dobutamine